CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

XRHealth notes the findings could lead to a discussion in the medical industry about using non-pharmaceutical interventions during surgical procedures that both enhance the patient experience during surgery and provide a better postoperative recovery.

Prospective data from 78 adult patients with chronic migraines in the U.S. demonstrated effectiveness of REN across four parameters in comparison to standard-care medications.

“With strong clinical evidence including two level I randomized controlled trials and long-term data supporting the efficacy and safety of BVN ablation, this treatment option has taken an increasingly important role in the approach to treating chronic vertebrogenic low back pain in recent years,” said Professor Dawood Sayed M.D

The analysis examined 143 consecutive patients with cardiogenic shock due to myocarditis who received Impella support or Impella plus VA ECMO support, known as ECpella. These patients are included in the J-PVAD registry, a registry conducted by 10 Japanese professional societies, including the Japanese Circulation Society (JCS).

In the paper, A Retrospective Assessment of Midline Catheter Failures Focusing on Catheter Composition, complication rates are compared in 101 standard midline catheters and 104 HydroMID® catheters.

Study shows VivAer was effective in reducing symptoms of nasal airway obstruction for patients with both dynamic and static nasal valve collapse.

Michel Reijnen, MD, PhD, principal investigator for AAA-SHAPE Netherlands and vascular surgeon at Rijnstate Hospital in Arnhem, the Netherlands added, “Although we are still early in the course of patient follow-up, we are seeing signals of impressive sac shrinkage at six months and one year. We look forward to the ongoing evaluation of these patients and how their aneurysms respond longer-term.”

The eShunt System is a minimally invasive method of treating communicating hydrocephalus. The eShunt System includes a proprietary eShunt Delivery System and the eShunt Implant, a permanent implant deployed in a minimally invasive, neuro-interventional procedure.

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success reports Medtronic.